Skip to content

The Effects of Seasonal Changes in Osteoporosis Treatment

The Effects of Seasonal Changes in Osteoporosis Treatment

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02977949
Enrollment
200
Registered
2016-11-30
Start date
2012-01-31
Completion date
2019-12-31
Last updated
2016-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Selective Estrogen Receptor Modulator (SERM)

Keywords

SERM, Season, Variation, Vitamin D

Brief summary

There are few reports concerning to the seasonal variation of osteoporosis treatment. In this study, we plan to compare clinical efficacy and safety by seasons.

Detailed description

Vitamin D insufficiency is common in many countries. Vitamin D insufficiency is associated with osteoporosis and the responses to osteoporosis treatment. 25-hydroxyvitamin D (25OHD) is considered to be the best estimate of body stores of vitamin D and the seasonal variation of 25OHD is well known. But there are few reports concerning to the seasonal variation of osteoporosis treatment. In this study, we plan to compare clinical efficacy and safety by seasons in patients treated by raloxifene.

Interventions

DRUGRaloxifene

Sponsors

Toshihiko Kono
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
45 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Postmenopausal women

Exclusion criteria

* Patients who could not use SERM

Design outcomes

Primary

MeasureTime frame
Effects of raloxifene on bone mineral density in postmenopausal osteoporosis.Up to 36 months

Countries

Japan

Contacts

Primary ContactRui Niimi, MD
furikakefuri@hotmail.co.jp(81)-59-365-0023

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026